Skip to Main Content

Author Details

Eric D Austin
Vanderbilt University Medical Center
2007
158
45
PMIDPaper TitleJournal TitlePublished Year
37879559Exploring the Association of Male Sex With Adverse Outcomes in Severe Bronchopulmonary Dysplasia: A Retrospective, Multicenter Cohort Study.Chest2024
38008306Genetic Testing in Pulmonary Arterial Hypertension Evaluation: A Patient and Clinician Survey.Chest2024
37937888Number of children in the household influences respiratory morbidities in children with bronchopulmonary dysplasia in the outpatient setting.Pediatr Pulmonol2024
36027975Pulmonary Hypertension in Children with Down Syndrome: Results from the Pediatric Pulmonary Hypertension Network Registry.J Pediatr2023
37915400Kids Mod PAH trial: A multicenter trial comparing mono- versus duo-therapy for initial treatment of pediatric pulmonary hypertension.Pulm Circ2023
37517916Recent Advances in Pediatric Pulmonary Hypertension: Implications for Diagnosis and Treatment.Clin Ther2023
37517653Measurement of Physical Activity by Actigraphy in Infants and Young Children with Pulmonary Arterial Hypertension.J Pediatr2023
38094686Development of a Peripherally Restricted 5-HT<sub>2B</sub> Partial Agonist for Treatment of Pulmonary Arterial Hypertension.JACC Basic Transl Sci2023
37674873Low-affinity insulin-like growth factor binding protein 7 and its association with pulmonary arterial hypertension severity and survival.Pulm Circ2023
37123538Multiomics endotyping of preterm infants with bronchopulmonary dysplasia and pulmonary hypertension-A pilot study.Pulm Circ2023
37122061Respiratory Outcomes for Ventilator-Dependent Children With Bronchopulmonary Dysplasia.Pediatrics2023
37152104Insulin-like growth factor binding Protein-4: A novel indicator of pulmonary arterial hypertension severity and survival.Pulm Circ2023
37295875Developing a Broader Understanding of Pediatric PAH Worldwide.Chest2023
36743426Transpulmonary generation of cell-free hemoglobin contributes to vascular dysfunction in pulmonary arterial hypertension via dysregulated clearance mechanisms.Pulm Circ2023
36793145Validation of an outpatient questionnaire for bronchopulmonary dysplasia control.Pediatr Pulmonol2023
36367783Molecular Function and Contribution of <i>TBX4</i> in Development and Disease.Am J Respir Crit Care Med2023
34687693Biomarkers of Pulmonary Hypertension Are Altered in Children with Down Syndrome and Pulmonary Hypertension.J Pediatr2022
35442875Is It Still "Idiopathic"? Features of Autoimmunity in Idiopathic Pulmonary Arterial Hypertension.Am J Respir Crit Care Med2022
35803300Daycare Attendance is Linked to Increased Risk of Respiratory Morbidities in Children Born Preterm with Bronchopulmonary Dysplasia.J Pediatr2022
35769420<i>COL18A1</i> genotypic associations with endostatin levels and clinical features in pulmonary arterial hypertension: a quantitative trait association study.ERJ Open Res2022
35506100Hepatoma-derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survival.Pulm Circ2022
35437911Insurance coverage and respiratory morbidities in bronchopulmonary dysplasia.Pediatr Pulmonol2022
35713625Leveraging Therapy-Specific Polygenic Risk Scores to Predict Restrictive Lung Defects in Childhood Cancer Survivors.Cancer Res2022
35514776Proteomics discovery of pulmonary hypertension biomarkers: Insulin-like growth factor binding proteins are associated with disease severity.Pulm Circ2022
35864912Caveolin-1 associated with severe (pediatric-onset) presentation of pulmonary arterial hypertension.Pulm Circ2022
35049414Cardiac Catheterization and Hemodynamics in a Multicenter Cohort of Children with Pulmonary Hypertension.Ann Am Thorac Soc2022
35103566Upfront Combination Therapy: Growing the Case to Get Ahead of Pediatric Pulmonary Arterial Hypertension.Ann Am Thorac Soc2022
32407592Estrogen Signaling and Portopulmonary Hypertension: The Pulmonary Vascular Complications of Liver Disease Study (PVCLD2).Hepatology2021
33522875Sex Hormones across the Menstrual Cycle in Pulmonary Arterial Hypertension: Adding a New Layer of Complexity.Ann Am Thorac Soc2021
33713587Characteristics of infants or children presenting to outpatient bronchopulmonary dysplasia clinics in the United States.Pediatr Pulmonol2021
33836561Type I interferon activation and endothelial dysfunction in caveolin-1 insufficiency-associated pulmonary arterial hypertension.Proc Natl Acad Sci U S A2021
33609516ST2 Is a Biomarker of Pediatric Pulmonary Arterial Hypertension Severity and Clinical Worsening.Chest2021
34908518Outpatient Respiratory Management of Infants, Children, and Adolescents with Post-Prematurity Respiratory Disease: An Official American Thoracic Society Clinical Practice Guideline.Am J Respir Crit Care Med2021
34707859Liver abnormalities in pulmonary arterial hypertension.Pulm Circ2021
34622662Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease-Associated Pulmonary Hypertension.J Am Heart Assoc2021
34651041The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertension.ERJ Open Res2021
34324276Pulmonary hypertension in the child with bronchopulmonary dysplasia.Pediatr Pulmonol2021
34065088KCNK3 Mutation Causes Altered Immune Function in Pulmonary Arterial Hypertension Patients and Mouse Models.Int J Mol Sci2021
34140292Characterisation of paediatric pulmonary hypertensive vascular disease from the PPHNet Registry.Eur Respir J2021
31917901Genes that drive the pathobiology of pediatric pulmonary arterial hypertension.Pediatr Pulmonol2021
33385213TBX4 Transcription Factor Is a Positive Feedback Regulator of Itself and Phospho-SMAD1/5.Am J Respir Cell Mol Biol2021
32521539Pulmonary hypertension in bronchopulmonary dysplasia.Pediatr Res2021
31513751Beyond the Lungs: Systemic Manifestations of Pulmonary Arterial Hypertension.Am J Respir Crit Care Med2020
32029443Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertension.Eur Respir J2020
32053755Deconstructing the Melting Pot in Pulmonary Arterial Hypertension.Am J Respir Crit Care Med2020
31987881Noninvasive Prognostic Biomarkers for Left-Sided Heart Failure as Predictors of Survival in Pulmonary Arterial Hypertension.Chest2020
32692583Novel Documentation of Onset and Rapid Advancement of Pulmonary Arterial Hypertension without Symptoms in BMPR2 Mutation Carriers: Cautionary Tales?Am J Respir Crit Care Med2020
32711743Elevated Interleukin-6 Levels Predict Clinical Worsening in Pediatric Pulmonary Arterial Hypertension.J Pediatr2020
33019943Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survival.BMC Med2020
33015095Expression of a Human Caveolin-1 Mutation in Mice Drives Inflammatory and Metabolic Defect-Associated Pulmonary Arterial Hypertension.Front Med (Lausanne)2020
  • 1 - 50 of 158

Recommended Authors

Intermountain Medical Center
Career Start Year 2016
Number of shared co-authors 1
Wake Forest University School of Medicine
Career Start Year 2016
Number of shared co-authors 3
AHEPA University Hospital, Aristotle University of Thessaloniki
Career Start Year 2016
Number of shared co-authors 0
New York Presbyterian Morgan Stanley Children's Hospital
Career Start Year 2014
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2013
Number of shared co-authors 7
Emory University
Career Start Year 2012
Number of shared co-authors 3
Boston Children's Hospital, Harvard Medical School
Career Start Year 2012
Number of shared co-authors 5
University of Alabama at Birmingham
Career Start Year 2009
Number of shared co-authors 2
Levine Children's Hospital
Career Start Year 2007
Number of shared co-authors 1
Stanford University
Career Start Year 2005
Number of shared co-authors 3
Heart Institute, Cincinnati Children's Hospital Medical Center
Career Start Year 2003
Number of shared co-authors 8
University of Missouri-Kansas City School of Medicine
Career Start Year 2003
Number of shared co-authors 1
University of Pittsburgh
Career Start Year 2003
Number of shared co-authors 6
University of Pittsburgh
Career Start Year 2002
Number of shared co-authors 3
Massachusetts General Hospital.
Career Start Year 2000
Number of shared co-authors 1
University of Rochester
Career Start Year 2000
Number of shared co-authors 5
University of Colorado School of Medicine and Children's Hospital Colorado
Career Start Year 2000
Number of shared co-authors 7
Harvard Medical School
Career Start Year 2000
Number of shared co-authors 1
The University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
Medical College of Wisconsin
Career Start Year 1998
Number of shared co-authors 6
Hospital for Sick Children
Career Start Year 1997
Number of shared co-authors 11
Yale Cardiovascular Research Center, Yale University School of Medicine
Career Start Year 1996
Number of shared co-authors 3
From the University of California San Diego School of Medicine
Career Start Year 1995
Number of shared co-authors 0
University of Cincinnati
Career Start Year 1994
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 1994
Number of shared co-authors 0
National Institutes of Health, and Blood Institute
Career Start Year 1994
Number of shared co-authors 0
National Heart & Lung Institute, Imperial College London.
Career Start Year 1992
Number of shared co-authors 2
Brigham and Women's Hospital
Career Start Year 1989
Number of shared co-authors 6
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1986
Number of shared co-authors 6
Icahn School of Medicine at Mount Sinai
Career Start Year 1985
Number of shared co-authors 9

Collaborators

Vanderbilt University Medical Center
Co-authored papers 29
Heart Institute, Children's Hospital Colorado, University of Colorado
Co-authored papers 26
Johns Hopkins University School of Medicine
Co-authored papers 18
Boston Children's Hospital, Harvard Medical School
Co-authored papers 16
Department of Pediatrics Boston Children's Hospital Boston Massachusetts USA.
Co-authored papers 14
Children's Hospital Colorado
Co-authored papers 12
University of California San Francisco
Co-authored papers 11
Vanderbilt University Medical Center
Co-authored papers 11
Co-authored papers 8
Cincinnati Children's Hospital Medical Center
Co-authored papers 8
University of Colorado School of Medicine
Co-authored papers 6
Co-authored papers 5
Stanford University School of Medicine
Co-authored papers 5
Co-authored papers 4
Boston Children's Hospital
Co-authored papers 4
Heart and Lung Research Institute, University of Cambridge
Co-authored papers 4
University of Vermont
Co-authored papers 3
Co-authored papers 3
Center for Precision Health, The University of Texas Health Science Center at Houston
Co-authored papers 3
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Regeneron Pharmaceuticals, Inc.
Co-authored papers 2
Regeneron Pharmaceuticals
Co-authored papers 2
Co-authored papers 2
Boston Children's Hospital.
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Columbia University
Co-authored papers 2
Co-authored papers 2
Duke Clinical Research Institute, Duke University School of Medicine
Co-authored papers 1